Vincent Lapointe

735 total citations
26 papers, 476 citations indexed

About

Vincent Lapointe is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Vincent Lapointe has authored 26 papers receiving a total of 476 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Pulmonary and Respiratory Medicine, 7 papers in Oncology and 6 papers in Surgery. Recurrent topics in Vincent Lapointe's work include Prostate Cancer Diagnosis and Treatment (13 papers), Prostate Cancer Treatment and Research (12 papers) and Management of metastatic bone disease (6 papers). Vincent Lapointe is often cited by papers focused on Prostate Cancer Diagnosis and Treatment (13 papers), Prostate Cancer Treatment and Research (12 papers) and Management of metastatic bone disease (6 papers). Vincent Lapointe collaborates with scholars based in Canada, Australia and Ireland. Vincent Lapointe's co-authors include Ingrid Spadinger, Mira Keyes, William Morris, Tom Pickles, Michael McKenzie, Veronika Moravan, Stacy Miller, Mitchell Liu, Ross Halperin and Howard Pai and has published in prestigious journals such as International Journal of Radiation Oncology*Biology*Physics, The Journal of Organic Chemistry and Organic Letters.

In The Last Decade

Vincent Lapointe

24 papers receiving 472 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Vincent Lapointe Canada	11	393	216	79	77	58	26	476
Stacy Miller Canada	8	262 0.7×	143 0.7×	101 1.3×	80 1.0×	44 0.8×	16	368
Kazuhito Toya Japan	13	351 0.9×	204 0.9×	86 1.1×	45 0.6×	55 0.9×	41	422
E. Martinez Spain	9	242 0.6×	86 0.4×	83 1.1×	37 0.5×	26 0.4×	20	332
J. Livsey United Kingdom	11	132 0.3×	106 0.5×	170 2.2×	38 0.5×	56 1.0×	19	340
Moon Ki Jo South Korea	9	248 0.6×	53 0.2×	54 0.7×	56 0.7×	52 0.9×	17	327
Thomas Yung United States	13	334 0.8×	190 0.9×	55 0.7×	51 0.7×	46 0.8×	43	384
Tadashi Takenaka Japan	13	126 0.3×	118 0.5×	160 2.0×	20 0.3×	99 1.7×	37	403
Steven Leibel United States	8	279 0.7×	156 0.7×	41 0.5×	84 1.1×	70 1.2×	15	322
Charlie Ma United States	6	407 1.0×	307 1.4×	40 0.5×	12 0.2×	112 1.9×	10	462
Taryn Torre United States	5	472 1.2×	284 1.3×	70 0.9×	53 0.7×	56 1.0×	5	524

Countries citing papers authored by Vincent Lapointe

Since Specialization

Citations

This map shows the geographic impact of Vincent Lapointe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vincent Lapointe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vincent Lapointe more than expected).

Fields of papers citing papers by Vincent Lapointe

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vincent Lapointe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vincent Lapointe. The network helps show where Vincent Lapointe may publish in the future.

Co-authorship network of co-authors of Vincent Lapointe

This figure shows the co-authorship network connecting the top 25 collaborators of Vincent Lapointe. A scholar is included among the top collaborators of Vincent Lapointe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vincent Lapointe. Vincent Lapointe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lapointe, Vincent, et al.. (2023). Synthesis of Substituted Indolines through Photocatalyzed Decarboxylative Radical Arylation. The Journal of Organic Chemistry. 88(10). 6557–6564. 1 indexed citations

Sit, Daegan, et al.. (2022). Association Between EGFR and ALK Mutation Status on Patient-Reported Symptoms After Palliative Radiation for Bone Pain in NSCLC. JTO Clinical and Research Reports. 3(8). 100371–100371. 2 indexed citations

Oh, Justin, William Morris, Ingrid Spadinger, et al.. (2022). After ASCENDE-RT: Biochemical and survival outcomes following combined external beam radiotherapy and low-dose-rate brachytherapy for high-risk and unfavourable intermediate-risk prostate cancer, a population-based analysis. Brachytherapy. 21(5). 605–616. 1 indexed citations

Hamilton, Sarah, Nicole G. Chau, Eric Berthelet, et al.. (2021). Patient-reported outcomes and complications during head and neck cancer radiotherapy before versus during the COVID-19 pandemic. Supportive Care in Cancer. 30(3). 2745–2753. 2 indexed citations

Hamilton, Sarah, Eric Tran, Cheryl Ho, et al.. (2020). Patient-reported outcome measures in patients undergoing radiotherapy for head and neck cancer. Supportive Care in Cancer. 29(5). 2537–2547. 15 indexed citations

Conway, Jessica L., Devin Schellenberg, Ross Halperin, et al.. (2016). Comparison of patient-reported outcomes with single versus multiple fraction palliative radiotherapy for bone metastasis in a population-based cohort. Radiotherapy and Oncology. 119(2). 202–207. 25 indexed citations

Keyes, Mira, Tom Pickles, Juanita Crook, et al.. (2015). Effect of aging and long-term erectile function after iodine-125 prostate brachytherapy. Brachytherapy. 14(3). 334–341. 15 indexed citations

Rodda, S., Stacy Miller, Vincent Lapointe, Jeremy Hamm, & William Morris. (2015). Short Term Androgen Deprivation Therapy Does Not Increase All-Cause Mortality in Men Treated With Low-Dose-Rate Prostate Brachytherapy: A Population-Based Cohort Study. Brachytherapy. 14. S34–S34.

Keyes, Mira, Stacy Miller, Tom Pickles, et al.. (2014). Late Urinary Side Effects 10 Years After Low-Dose-Rate Prostate Brachytherapy: Population-Based Results From a Multiphysician Practice Treating With a Standardized Protocol and Uniform Dosimetric Goals. International Journal of Radiation Oncology*Biology*Physics. 90(3). 570–578. 45 indexed citations

10.

Lo, Andrea, William Morris, Vincent Lapointe, et al.. (2013). Prostate-Specific Antigen at 4 to 5 Years After Low-Dose-Rate Prostate Brachytherapy Is a Strong Predictor of Disease-Free Survival. International Journal of Radiation Oncology*Biology*Physics. 88(1). 87–93. 49 indexed citations

11.

Moiseenko, Vitali, et al.. (2012). Biological consequences of MLC calibration errors in IMRT delivery and QA. Medical Physics. 39(4). 1917–1924. 17 indexed citations

12.

Herbert, Christopher, William Morris, Mira Keyes, et al.. (2012). Outcomes following iodine-125 brachytherapy in patients with Gleason 7, intermediate risk prostate cancer: A population-based cohort study. Radiotherapy and Oncology. 103(2). 228–232. 20 indexed citations

13.

Herbert, Christopher, William Morris, Mira Keyes, et al.. (2011). The Effect of Primary Gleason Pattern on Biochemical No Evidence of Disease (bNED) in Patients With Gleason 7, Localized Prostate Cancer Treated With 125I Brachytherapy. Brachytherapy. 10. S48–S49. 1 indexed citations

14.

Herbert, Christopher, William Morris, Jeremy Hamm, et al.. (2011). The effect of loose versus stranded seeds on biochemical no evidence of disease in patients with carcinoma of the prostate treated with iodine-125 brachytherapy. Brachytherapy. 10(6). 442–448. 9 indexed citations

15.

Hayden, Amy, Mira Keyes, Michael McKenzie, et al.. (2011). Erectile Function Following 125I Permanent Prostate Brachytherapy: 5- and 8-Year Results in 1411 Men. Brachytherapy. 10. S17–S17. 1 indexed citations

16.

Keyes, Mira, Tom Pickles, David A. Palma, et al.. (2010). Evaluating the Phoenix Definition of Biochemical Failure After 125I Prostate Brachytherapy: Can PSA Kinetics Distinguish PSA Failures From PSA Bounces?. International Journal of Radiation Oncology*Biology*Physics. 78(2). 415–421. 63 indexed citations

17.

Keyes, Mira, Stacy Miller, Veronika Moravan, et al.. (2009). Urinary Symptom Flare in 712 125I Prostate Brachytherapy Patients: Long-Term Follow-Up. International Journal of Radiation Oncology*Biology*Physics. 75(3). 649–655. 41 indexed citations

18.

Gagnon, F, et al.. (2008). Étude transversale sur l’approche thérapeutique des patients avec troubles thyroïdiens par les omnipraticiens du Québec. Annales d Endocrinologie. 69(3). 210–217. 1 indexed citations

19.

Morris, William, Mira Keyes, David A. Palma, et al.. (2008). LDR brachytherapy for prostate cancer: An analysis of outcomes for the first 1006 consecutive patients treated at the BC Cancer Agency. Brachytherapy. 7(2). 99–99. 1 indexed citations

20.

Keyes, Mira, Stacy Miller, Veronika Moravan, et al.. (2008). Predictive Factors for Acute and Late Urinary Toxicity After Permanent Prostate Brachytherapy: Long-Term Outcome in 712 Consecutive Patients. International Journal of Radiation Oncology*Biology*Physics. 73(4). 1023–1032. 138 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact